Gregory D. Lewis

Active 2006–2025

154
Papers
22,483
Citations
73
h-index
147
i10-index

Citations

Citations per year for Gregory D. Lewis1979: 1 citations1996: 8 citations2003: 1 citations2004: 2 citations2006: 2 citations2007: 5 citations2008: 10 citations2009: 48 citations2010: 56 citations2011: 109 citations2012: 162 citations2013: 220 citations2014: 226 citations2015: 254 citations2016: 317 citations2017: 261 citations2018: 282 citations2019: 781 citations2020: 930 citations2021: 922 citations2022: 927 citations2023: 662 citations2024: 1,239 citations2025: 649 citations2026: 14 citations1980–1995: no citations, so these years are not shown1997–2002: no citations, so these years are not shown2005: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,846 citing papers, 24.7% of this breakdownChina: 876 citing papers, 7.6% of this breakdownUnited Kingdom: 776 citing papers, 6.7% of this breakdownGermany: 638 citing papers, 5.5% of this breakdownItaly: 605 citing papers, 5.3% of this breakdownCanada: 458 citing papers, 4% of this breakdownNetherlands: 387 citing papers, 3.4% of this breakdownAustralia: 386 citing papers, 3.3% of this breakdownSpain: 300 citing papers, 2.6% of this breakdownJapan: 288 citing papers, 2.5% of this breakdownFrance: 286 citing papers, 2.5% of this breakdownSweden: 265 citing papers, 2.3% of this breakdown
0%24.7%Other 29.6%

Fields

  • Medicine65.7%
  • Biochemistry, Genetics and Molecular Biology27.5%
  • Neuroscience1.4%
  • Engineering1%
  • Chemistry0.8%
  • Nursing0.7%
  • Other2.9%

Topics

  • Cardiovascular Function and Risk Factors8.4%
  • Metabolomics and Mass Spectrometry Studies6.6%
  • Heart Failure Treatment and Management6%
  • Adipose Tissue and Metabolism3.5%
  • Cardiovascular and exercise physiology3.2%
  • Pulmonary Hypertension Research and Treatments3.2%
  • Other69.1%

Coauthors

All papers

Open in search
  1. Metabolite profiles and the risk of developing diabetes

    Authors: , , , , , , , , , , , , , , , , , - Nature Medicine 2011 cited by 3,149

  2. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2021 cited by 604

  3. Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa Meng, Amy Wohltman, Theodore P. Abraham - New England Journal of Medicine 2024 cited by 282

  4. Ferric Carboxymaltose in Heart Failure with Iron Deficiency

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 218

  5. β-Aminoisobutyric Acid Induces Browning of White Fat and Hepatic β-Oxidation and Is Inversely Correlated with Cardiometabolic Risk Factors

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cell Metabolism 2014 cited by 635

  6. Quality of Life in Heart Failure with Preserved Ejection Fraction: Importance of Obesity, Functional Capacity, and Physical Inactivity

    Authors: , , , , , , , , , , , - European Journal of Heart Failure 2020 cited by 237

  7. Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , for the RELAX Trial - JAMA 2013 cited by 1,130

  8. Cardiopulmonary Exercise Testing in Heart Failure

    Authors: , , , - JACC Heart Failure 2016 cited by 443

  9. Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study

    Authors: , , , , , , , , , , , , , - Mayo Clinic Proceedings 2019 cited by 138

  10. Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2021 cited by 176

  11. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2011 cited by 668

  12. Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , - Circulation Heart Failure 2014 cited by 416

  13. Pulmonary Capillary Wedge Pressure Patterns During Exercise Predict Exercise Capacity and Incident Heart Failure

    Authors: , , , , , , , , , , , - Circulation Heart Failure 2018 cited by 253

  14. Impaired Exercise Tolerance in Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , - JACC Heart Failure 2020 cited by 107

  15. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency

    Authors: , , , , , , , , , , , , , , , , , - JAMA 2017 cited by 452

  16. Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , , - Circulation 2016 cited by 252

  17. Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gina Ciezkowski, Glenda Herrera, Hirsch Mehta, Rosemarie Delucca, Sanjay Doddamani, Manreet Kanwar, B. Thomas, Laurie Machen, J. Kim, Athas Christina, Brent C. Lampert, Cindy Fontenelle, Clement Eiswirth, Julie Williams, Darlene Rock, Gregory F. Egnaczyk, Enya Rentas-Sherman, Deborah Barr, Arvind Bhimaraj, Adrianna Damato, Christine Calayo, John M. Herre, JoAnn Lindenfeld, Amanda Carroll, Mary Gordon, Mary Keebler, Bandaa Setliff, Sanjeev Gulati, K Winkler, Laura Curtin, Carly Ohmart, John Halvorson, James O. Mudd, S. Albert Camacho, Maryse Palardy, Neha Shah, Kristina Picardi, Arun Krishnamoorthy, Adrienne Maximin, Douglas Horstmanshof, Beverly Seiler, Zi J. Xu, S. Mersola, E. Kransdorf, W.H. Wilson Tang, T. Fonk, Eiran Z. Gorodeski, Guilherme H. Oliveira, Terrence Semenec, Nadine Norton, Julie Nichols, Peter Leo, Mark E. Dunlap, G. Michael Felker, Lacey D. Taylor, Mary Sheehan, Sharon Levine, Diane Cocca-Spofford, Liana Brooks, Thomas F. Cunningham, Nancy Acker, Susan Milbrandt, Janet Gatzke, Víctor G. Dávila‐Román, Anne Dirks, Karen Bult, Elizabeth Weber, Mary Lesko, Deana Mikhalkova, Kathleen Fitzgerald and 19 more - JAMA Cardiology 2021 cited by 175

  18. Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions

    Authors: , , , , , , , , , , - Cardiovascular Research 2022 cited by 79

  19. Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2012 cited by 595

  20. Cardiovascular Phenotype in HFpEF Patients With or Without Diabetes

    Authors: , , , , , , , , , , - Journal of the American College of Cardiology 2014 cited by 210

  21. Metabolic Signatures of Exercise in Human Plasma

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2010 cited by 423

  22. A Phase II study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT‐HF trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michelle Cohen, Lara M. Simpson, David Aguilar, Cătălin Loghin, Lem Moyé, Ray F. Ebert, Barry R. Davis, Robert D. Simari - European Journal of Heart Failure 2021 cited by 166

  23. Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luciana Sacilotto, Edmundo Arteaga, Murilo O. Antunes, E. Kevin Hall, Lubna Choudhury, Elfriede Pahl, Kimberly Y. Lin, Gregory D. Lewis, Akshay S. Desai, Kristin M. Burns, John J.V. McMurray, Calum A. MacRae, Scott D. Solomon, E. John Orav, Eugene Braunwald - Nature Medicine 2021 cited by 132

  24. Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA 2018 cited by 258